Top Markets
Coin of the day
Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.

SIGY
株式のランク #41132
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise... Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inflammatory cytokines such as tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6. The company is headquartered in San Diego, California.
株価
$0.025
最終同期: 2026-08-12
時価総額
$40.14K
変化(1日)
-35.90%
変化(1年)
-99.11%
US
取引 Sigyn Therapeutics, Inc. (SIGY)

カテゴリー

Sigyn Therapeutics, Inc.(SIGY)の配当利回りの履歴
Sigyn Therapeutics, Inc.(銘柄コード: SIGY)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Sigyn Therapeutics, Inc.(SIGY)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)